Nearly half of Finns with chronic conditions find medication therapy a burden
en-GBde-DEes-ESfr-FR

Nearly half of Finns with chronic conditions find medication therapy a burden


According to a recent study, 44% of people with chronic conditions who responded to a population-based survey experienced medication-related burden (MRB). The burden was most common among people with diabetes, heart disease, rheumatic disease or some other musculoskeletal disorder. The greatest burden was caused by factors associated with health care, such as fragmented care and the cost of medicines, as well as adverse drug reactions or concerns about them.

“Other factors linked with MRB were poor health status, limits on functional capacity and low income,” says Pharmacist and Doctoral Researcher Heidi Mikkola from the School of Pharmacy at the University of Eastern Finland. Mikkola also works as a researcher at the Finnish Medicines Agency Fimea.

Medication therapy plays an important role in treating many chronic conditions, but it can also cause significant burden in a patient’s daily life. MRB refers to the psychological, social and practical burden experienced by the patient in connection with using medicines. MRB can reduce adherence to treatment, lower patients’ quality of life and lead to increased healthcare costs.

“Identifying the illnesses and patient groups that involve the greatest risk of MRB will allow healthcare to allocate support and resources more efficiently,” says Mikkola.

The study shows that experiencing MRB is a common phenomenon at the population level and its prevalence varies across different chronic conditions. Healthcare professionals should take patient perspectives and the different dimensions of MRB into account so that treatment can be planned in an individual and patient-oriented manner.

The study performed by the University of Eastern Finland and Fimea utilised data from the 2021 Medicines Barometer population survey. The Medicines Barometer is a survey aimed at the population to investigate Finns' views and experiences regarding medicines. The population survey is conducted by Fimea every two years. The study utilised the survey responses of 1,323 Finns who had at least one diagnosed chronic condition and used prescription medications. The peer-reviewed research results were published in BMC Health Services Research. The study is part of Mikkola’s doctoral dissertation.

Research article:

Mikkola H, Hämeen-Anttila K, Airaksinen M, Dimitrow M, Saastamoinen L: Medication-related burden variation across chronic conditions: a population-based cross-sectional survey. BMC Health Services Research 2025;25:1283

Mikkola H, Aarnio E, Hämeen-Anttila K, Airaksinen M, Dimitrow M, Saastamoinen L: Medication-related burden variation across chronic conditions: a population-based cross-sectional survey. BMC Health Services Research 2025;25:1283
Regions: Europe, Finland
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Témoignages

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Nous travaillons en étroite collaboration avec...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by DNN Corp Terms Of Use Privacy Statement